PubRank

Marieke J H A Kruip

Author PubWeight™ 21.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006 4.75
2 Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts. BMJ 2010 1.99
3 Further validation and simplification of the Wells clinical decision rule in pulmonary embolism. Thromb Haemost 2008 1.61
4 Cardiovascular risk assessment in haemophilia patients. Thromb Haemost 2010 1.57
5 Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism. Blood 2013 1.51
6 The natural course of hemodynamically stable pulmonary embolism: Clinical outcome and risk factors in a large prospective cohort study. Chest 2007 1.12
7 Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism. Thromb Haemost 2012 0.97
8 Elevated fibrinogen gamma' ratio is associated with cardiovascular diseases and acute phase reaction but not with clinical outcome. Blood 2009 0.96
9 Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients. PLoS One 2012 0.85
10 Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis: similarities and differences. Arterioscler Thromb Vasc Biol 2011 0.83
11 Excluding pulmonary embolism without imaging tests--can our diagnostic algorithm be optimized? Thromb Haemost 2008 0.81
12 Reversible renal failure due to bilateral renal sarcoma in a patient with acute myeloid leukemia. Ren Fail 2009 0.80
13 On the treatment of new oral anticoagulant-associated gastrointestinal hemorrhage. J Gastrointestin Liver Dis 2013 0.80
14 Response to desmopressin is strongly dependent on F8 gene mutation type in mild and moderate haemophilia A. Thromb Haemost 2013 0.80
15 The "OPTI-CLOT" trial. A randomised controlled trial on periOperative PharmacokineTIc-guided dosing of CLOTting factor concentrate in haemophilia A. Thromb Haemost 2015 0.77
16 Risk and management of thrombosis in multiple myeloma. Thromb Res 2012 0.77
17 Clinically suspected acute recurrent pulmonary embolism: a diagnostic challenge. Thromb Haemost 2007 0.76
18 Control of anticoagulation with VKAs: overestimation of median TTR when assessed by linear interpolation: Reply. Thromb Haemost 2017 0.75
19 Point-of-care testing and INR within-subject variation in patients receiving a constant dose of vitamin K antagonist. Thromb Haemost 2015 0.75
20 Evaluation of the AutoDimer D-dimer assay for the exclusion of pulmonary embolism. Thromb Haemost 2007 0.75
21 Control of anticoagulation with vitamin K antagonists: overestimation of median time in therapeutic range when assessed by linear interpolation. Thromb Haemost 2016 0.75
22 Is a normal computed tomography pulmonary angiography safe to rule out acute pulmonary embolism in patients with a likely clinical probability? A patient-level meta-analysis. Thromb Haemost 2017 0.75
23 Thrombophylaxis and bleeding complications after cesarean section. Acta Obstet Gynecol Scand 2012 0.75
24 Optimization of the diagnostic management of clinically suspected pulmonary embolism in hospitalized patients. Br J Haematol 2014 0.75